Company Information & Financial DataAxalbion Therapeutics Limited
Registered address:
Directors
Current | Date Appointed |
---|---|
Reveal name
Manchester, Greater Manchester, M23
|
24 Feb 2021 |
Reveal name
London, London, WC2N
|
16 Mar 2021 |
Source: Companies House
Summary Balance Sheet
For more information on Abbreviated Accounts please click here:
http://www.companieshouse.gov.uk/about/gbhtml/gp2.shtml#ch6
Years
Net Worth Cash
31 Dec 2021
£ |
31 Dec 2022
£ |
||
---|---|---|---|
Total Asset |
31 Dec 2021
31 Dec 2022
|
£1,092,199 | £1,039,455 |
Current Asset |
31 Dec 2021
31 Dec 2022
|
£1,092,199 | £1,039,455 |
Current Liabilities |
31 Dec 2021
31 Dec 2022
|
£358,417 | £875,472 |
Net Current Assets |
31 Dec 2021
31 Dec 2022
|
£733,782 | £163,983 |
Net Current Liabilities |
31 Dec 2021
31 Dec 2022
|
£358,417 | £353,881 |
Net Worth |
31 Dec 2021
31 Dec 2022
|
£733,782 | £163,983 |
Cash |
31 Dec 2021
31 Dec 2022
|
£433,454 | £46,883 |
Profit & Loss Reserve |
31 Dec 2021
31 Dec 2022
|
£-2,074,161 | £-3,906,939 |
Source: Companies House
Other Businesses At This Address
Company Name | Classification | Company Number |
---|---|---|
Medicines Evaluation Unit
|
Research and Laboratory Based Activities | 03779957 |
Mi-trial Limited
|
Computer Software (Development) | 13657025 |
North West Lung Centre
T:
0161 946 4058
|
Alternative Medical Treatments and Therapies | 03936652 |
Key: N/A = Not Available